Mapp Biopharmaceutical Company Profile

17:59 EDT 26th September 2017 | BioPortfolio

Mapp Biopharmaceutical was founded in 2003 to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.

As Mapp's products transition to clinical evaluation, licenses are transferred to Mapp's commercialization partner, LeafBio.

ZMapp is composed of three “humanized” monoclonal antibodies manufactured in plants, specifically Nicotiana. It is an optimized cocktail combining the best components of MB--‐003 (Mapp) and ZMAb (Defyrus/PHAC).


6160 Lusk Blvd.Suite C105
San Diego
United States of America


Phone: 800 372 2176

News Articles [171 Associated News Articles listed on BioPortfolio]

MAP Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Jan. 2, 2013 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Company will present at the 31st Annual J.P. Morgan Healthcare Conference on ...

MAP Pharmaceuticals to Present at Upcoming Investor Conferences

MOUNTAIN VIEW, Calif., Nov. 3, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced that the Company will participate in the following investor conferences in November 2011: C...

Compulsory licensing: A misused and abused international trade law, says PhRMA

To maintain its position as the world’s top biopharmaceutical innovator, the US biopharmaceutical industry…

Policy conditions make or break leaders in biopharmaceutical innovation: Preliminary results from the 2017 BCI Survey

In a world of global investment flows, securing a larger portion of the $150 billion invested per year by the research-based biopharmaceutical industry is anyone’s game. The 2017 results...

Biopharmaceutical CMO CRO Market to Value $37. ...

The global biopharmaceutical CMO & CRO (contract manufacturing & research) market is expected to reach USD 37.8 billionby 2025, according to this new report. Read more...

How biopharmaceutical collaboration is driving a new era of medicine

Biopharmaceutical innovation, coupled with technological advancements, has brought a new era of medicine transforming how we research and develop new medicines to benefit patients.

Examining the brain in The New Era of Medicine

Biopharmaceutical innovation is powering a rapid pace of medical breakthroughs and scientific advancements.  America’s biopharmaceutical companies are working day in and day out to ...

inVentiv Health Consulting Releases Ninth Annual Survey of Biopharmaceutical Dealmakers, ...

The study, which was released during a Super Session at the BIO International Convention, provides a review of biopharmaceutical dealmakers' intentions for the next twelve Read more...

Drugs and Medications [0 Results]


PubMed Articles [109 Associated PubMed Articles listed on BioPortfolio]

Exploring the potential of Saccharomyces cerevisiae for biopharmaceutical protein production.

Production of recombinant proteins by yeast plays a vital role in the biopharmaceutical industry. It is therefore desirable to develop yeast platform strains for over-production of various biopharmace...

Evaluating ultraviolet sensitivity of adventitious agents in biopharmaceutical manufacturing.

Incidents of contamination in biopharmaceutical production have highlighted the need to apply alternative or supplementary disinfection techniques. Ultraviolet (UV) irradiation is a well-established m...

Purification of monoclonal antibodies entirely in flow-through mode.

A depth filter is widely used in biopharmaceutical manufacturing process. In this study, we found that buffer exchange to reduce conductivity dramatically improved the removal of impurities in depth f...


Rejoinder to Chen's letter.

Clinical Trials [8 Associated Clinical Trials listed on BioPortfolio]

Trans-MAPP Symptom Patterns Study (SPS)

This study is the second phase of the MAPP Network and is designed to conduct a prospective, observational study of men and women with UCPPS, referred to as the Symptom Patterns Study (SPS...

Trans-MAPP II Study of Urologic Chronic Pelvin Pain

The Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network has been established by the National Institute of Diabetes and Digestive and Kidney Diseases (NID...

Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis

Mycobacterium Vaccae for Injection (Trade Name "Vaccae") is a kind of bio-products developed by Anhui Zhifei Longcom Biopharmaceutical Co.,Ltd.,and got "The New Drug Certificate "in 1999...

A Positron Emission Tomography (PET) Imaging Study to Investigate the Biodistribution and Clearance of an Albumin Binding Domain Antibody (AlbudAb) GSK3128349 in Healthy Male Subjects

GSK3128349 is a small protein molecule (biopharmaceutical) that binds to albumin in the body, and by itself, has no pharmacological action. A pharmacologically active drug can be attached ...

Juvista in the Non-surgical Improvement of Existing Scars

Renovo, a Biopharmaceutical company involved in the development of drugs to improve the appearance of scars and enhance wound healing, are proposing to carry out research in improving the ...

Companies [850 Associated Companies listed on BioPortfolio]

Mapp Biopharmaceutical

Mapp Biopharmaceutical was founded in 2003 to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense. As Mapp'...

Barrier Animal Healthcare

For far too long the control of Ragwort has been haphazard, unreliable and costly, that is until now. Barrier H is an innovation in Ragwort control, destroying this deadly weed in record time, right t...

Bavarian Nordic Research Institute A/S

Bavarian Nordic is a commercially viable international biopharmaceutical company through:Biopharmaceutical innovations Novel prophylactic and therapeutic approaches Development, production, testing an...

bde BioPharmaceutical Resources

bde BioPharmaceutical Resources is affiliated with a consortium of companies & consultants whose expertise can be utilized to perform a full spectrum of regulatory, scientific & manufacturing function...

Biopartners GmbH

BioPartners is an international biopharmaceutical company specialising in accelerating the global development and commercialisation of high quality recombinant biopharmaceutical products.

More Information about "Mapp Biopharmaceutical" on BioPortfolio

We have published hundreds of Mapp Biopharmaceutical news stories on BioPortfolio along with dozens of Mapp Biopharmaceutical Clinical Trials and PubMed Articles about Mapp Biopharmaceutical for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mapp Biopharmaceutical Companies in our database. You can also find out about relevant Mapp Biopharmaceutical Drugs and Medications on this site too.

Quick Search

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record